Log in

Relevant bibliographies by topics / Bone disease / Books

Books on the topic 'Bone disease'

To see the other types of publications on this topic, follow the link: Bone disease.

Author: Grafiati

Published: 4 June 2021

Last updated: 10 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Bone disease.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

McKillop, James H. Benign and malignant bone disease. Edinburgh: Churchill Livingstone, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

R, Reid I., ed. Metabolic bone disease. London: Baillière Tindall, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Lecka-Czernik, Beata, and John L. Fowlkes, eds. Diabetic Bone Disease. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-16402-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Diel, Ingo J., M. Kaufmann, and G. Bastert, eds. Metastatic Bone Disease. Berlin, Heidelberg: Springer Berlin Heidelberg, 1994. http://dx.doi.org/10.1007/978-3-642-78596-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Roodman, G. David, ed. Myeloma Bone Disease. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-554-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Randall, R. Lor, ed. Metastatic Bone Disease. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4614-5662-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Roodman, G. David. Myeloma bone disease. New York: Humana, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

D, Tiegs Robert, ed. Metabolic bone disease. Philadelphia: Saunders, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

D, Tiegs Robert, ed. Metabolic bone disease. Philadelphia: Saunders, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

J, Maricic Michael, and Gluck Oscar S. 1949-2003, eds. Bone disease in rheumatology. Philadelphia: Lippincott Williams & Willkins, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

V, Avioli Louis, and Krane Stephen M, eds. Metabolic bone disease and clinically related disorders. 2nd ed. Philadelphia: W.B. Saunders Co., 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Yamaguchi, Masayoshi. Osteocalcin: Production, regulation, and disease. Hauppauge, N.Y: Nova Science Publishers, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Singer, Frederick R., and Stanley Wallach, eds. Paget’s Disease of Bone. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4684-2307-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Patel, Vinood B., and Victor R. Preedy, eds. Biomarkers in Bone Disease. Dordrecht: Springer Netherlands, 2017. http://dx.doi.org/10.1007/978-94-007-7693-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Preedy, Victor R., ed. Biomarkers in Bone Disease. Dordrecht: Springer Netherlands, 2016. http://dx.doi.org/10.1007/978-94-007-7745-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

G, Ward William, and Peabody Terrance D, eds. Orthopedic management of metastatic disease. Philadelphia: W.B. Saunders, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Paul, Grech, ed. Diagnosis of metabolic bone disease. London: Chapman and Hall Medical, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

S, Tam Cherk, Heersche Johannes N. M, and Murray Timothy M, eds. Metabolic bone disease: Cellular and tissue mechanisms. Boca Raton, Fla: CRC Press, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Orthopaedic management of metastatic bone disease. St. Louis: Mosby, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Hukkanen, Mika V. J., 1962-, Polak Julia M, Hughes Sean, and Royal Postgraduate Medical School, eds. Nitric oxide in bone and joint disease. Cambridge, UK: Cambridge University Press, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Mone, Zaidi, ed. Skeletal development and remodeling in health, disease, and aging. Boston, Mass: Blackwell Pub. on behalf of the New York Academy of Sciences, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

A, Morris H., Need A. G, and Nordin B. E. C, eds. Metabolic bone and stone disease. 3rd ed. Edinburgh: Churchill Livingstone, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

C, Nordin B. E., Need A. G, and Morris H. A, eds. Metabolic bone and stone disease. 3rd ed. Edinburgh: Churchill Livingstone, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Conference on Skeletal Biology and Medicine (4th 2011 New York, N.Y.). Skeletal biology and medicine II: Bone and cartilage homeostasis and bone disease. Edited by Zaidi Mone. Boston, Mass: Published by Blackwell Pub. on behalf of the New York Academy of Sciences, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Musculoskeletal disease: Staged for rapid comprehension. Chicago: Year Book Medical Publishers, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

C, Stevenson John, ed. New techniques in metabolic bone disease. London: Wright, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

E, Bonucci, and Motta Pietro M, eds. Ultrastructure of skeletal tissues: Bone and cartilage in health and disease. Boston: Kluwer Academic Publishers, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

I, Tovey F., and Stamp T. C. B, eds. The measurement of metabolic bone disease. New York: Parthenon Pub. Group, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Rachel, Ives, and ScienceDirect (Online service), eds. The bioarchaeology of metabolic bone disease. Amsterdam: Elsevier/Academic Press, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Fleisch, Herbert. Bisphosphonates in bone disease: From the laboratory to the patient. Bern: H. Fleish, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

W, Weissman Barbara N., ed. Imaging of arthritis and metabolic bone disease. Philadelphia, PA: Mosby/Elsevier, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

J, Diel I., Kaufman M. 1946-, Bastert G. B, and European Symposium on Calcified Tissues (3rd : 1993 : Heidelberg, Germany), eds. Metastatic bone disease: Fundamental and clinical aspects. Berlin: Springer-Verlag, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Avioli, Louis V., and Stephen M. Krane. Metabolic Bone Disease: Volume II. Elsevier Science & Technology Books, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

Avioli, Louis V., and Stephen M. Krane. Metabolic Bone Disease: Volume 1. Elsevier Science & Technology Books, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

Ralston, Stuart H. Paget’s disease of bone. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0144.

Full text

Abstract:

Paget's disease of bone (PDB) affects up to 1% of people of European origin aged 55 years and above. It is characterized by focal abnormalities of bone remodelling which disrupt normal bone architecture, leading to expansion and reduced mechanical strength of affected bones. This can lead to various complications including deformity, fracture, nerve compression syndromes, and osteoarthritis, although many patients are asymptomatic. Genetic factors play a key role in the pathogenesis of PDB. This seems to be mediated by a combination of rare genetic variants which cause familial forms of the disease and common variants which increase susceptibility to environmental triggers. Environmental factors which have been suggested to predispose to PDB include viral infections, calcium and vitamin D deficiency, and excessive mechanical loading of affected bones. The diagnosis can be made by the characteristic changes seen on radiographs, but isotope bone scans are helpful in defining disease extent. Serum alkaline phosphatase levels can be used as a measure of disease activity. Inhibitors of bone resorption are the mainstay of medical management for PDB and bisphosphonates are regarded as the treatment of choice. Bisphosphonates are highly effective at reducing bone turnover in PDB and have been found to heal osteolytic lesions, and normalize bone histology. Although bisphosphonates can improving bone pain caused by elevated bone turnover, most patients require additional therapy to deal with symptoms associated with disease complications. It is currently unclear whether bisphosphonate therapy is effective at preventing complications of PDB.

APA, Harvard, Vancouver, ISO, and other styles

36

Ralston, Stuart H. Paget’s disease of bone. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199642489.003.0144_update_001.

Full text

Abstract:

Paget’s disease of bone (PDB) affects up to 1% of people of European origin aged 55 years and above. It is characterized by focal abnormalities of bone remodelling which disrupt normal bone architecture, leading to expansion and reduced mechanical strength of affected bones. This can lead to various complications including deformity, fracture, nerve compression syndromes, and osteoarthritis, although many patients are asymptomatic. Genetic factors play a key role in the pathogenesis of PDB. This seems to be mediated by a combination of rare genetic variants which cause familial forms of the disease and common variants which increase susceptibility to environmental triggers. Environmental factors which have been suggested to predispose to PDB include viral infections, calcium and vitamin D deficiency, and excessive mechanical loading of affected bones. The diagnosis can be made by the characteristic changes seen on radiographs, but isotope bone scans are helpful in defining disease extent. Serum alkaline phosphatase levels can be used as a measure of disease activity. Inhibitors of bone resorption are the mainstay of medical management for PDB and bisphosphonates are regarded as the treatment of choice. Bisphosphonates are highly effective at reducing bone turnover in PDB and have been found to heal osteolytic lesions, and normalize bone histology. Although bisphosphonates can improving bone pain caused by elevated bone turnover, most patients require additional therapy to deal with symptoms associated with disease complications. It is currently unclear whether bisphosphonate therapy is effective at preventing complications of PDB.

APA, Harvard, Vancouver, ISO, and other styles

37

Gikas, Panagiotis D., and Timothy W. R. Briggs. Metastatic bone disease. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780199550647.003.002007.

Full text

Abstract:

♦ Metastatic pathological fractures rarely unite, even if stabilized♦ Never rush to fix a pathological fracture; traction or splintage will suffice while investigations are performed and surgical intervention discussed♦ When surgery is indicated for spinal metastases, both decompression and stabilization are generally required♦ Implants should allow immediate weight-bearing and last the lifetime of the patient♦ Always use a multidisciplinary team.

APA, Harvard, Vancouver, ISO, and other styles

38

Metabolic bone disease. Philadelphia: Saunders, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

Martin. Metabolic Bone Disease. Elsevier, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

Myeloma Bone Disease. Humana, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

(Editor), R. Coleman, and Robert D. Rubens (Editor), eds. Metastatic Bone Disease. Taylor & Francis Ltd, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Roodman, G. David. Myeloma Bone Disease. Humana Press, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Bone disease in rheumatology. Philadelphia, PA: Lippincott Williams & Wilkins, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

Diagnosis Metabol Bone Disease. Lippincott Williams & Wilkins Publishers, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

Handbook of cancer-related bone disease. BioScientifica, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Anderson, Paul, Borje Edgar Christopher Nordin, and Howard Arthur Morris. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

47

Anderson, Paul, Borje Edgar Christopher Nordin, and Howard Arthur Morris. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Anderson, Paul. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

49

Anderson, Paul. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

50

Javaid, Kassim. Paget’s disease of bone. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0274.

Full text

Abstract:

Paget’s disease of bone is an uncommon bone disorder with increased bone resorption and disorganized bone formation of woven bone. Its cause is unclear; there is a clear genetic component but additional environmental factors are important, given the reduction in severity and prevalence in the UK. Paget’s disease is usually asymptomatic and detected by an unexplained raised alkaline phosphatase on routine biochemistry. Symptoms include focal bone pain, including headache. Other symptoms include bone deformity and complications such as fracture and nerve conduction. Paget’s disease can sometimes present with immobilization-associated hypercalcaemia or high-output cardiac failure, and rarely can transform to an osteosarcoma. This chapter addresses the clinical features, diagnosis, and management of Paget’s disease of bone.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!